- Home
- SYNX vs ADIL Comparison
SYNX vs ADIL Comparison
Compare SYNX & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYNX | ADIL |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5M | 7.8M |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SYNX | ADIL |
|---|---|---|
| Price | $0.77 | $0.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 208.5K | ★ 360.6K |
| Earning Date | 09-26-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,003,000.00 | N/A |
| Revenue This Year | $32.35 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.76 | $0.22 |
| 52 Week High | $6.49 | $1.30 |
Technical Indicators
Market Signals| Indicator | SYNX | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 32.52 | 29.13 |
| Support Level | $0.76 | $0.30 |
| Resistance Level | $0.86 | $0.29 |
| Average True Range (ATR) | 0.14 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 6.35 | 2.56 |
Price Performance
Historical ComparisonAbout SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.